established

Evolocumab Demonstrates Significant Reduction in Primary Cardiovascular Events Among High-Risk Diabetes Patients Without Established Atherosclerosis

In a landmark presentation at the American College of Cardiology’s Annual Scientific Session & Expo, researchers from Mass General Brigham…